164 related articles for article (PubMed ID: 37086183)
1. Novel formulations for topical delivery of tranexamic acid: assessing the need of epidermal targeting for hyperpigmentation disorders.
Verma P; Yadav KS
Expert Opin Drug Deliv; 2023 Jun; 20(6):773-783. PubMed ID: 37086183
[TBL] [Abstract][Full Text] [Related]
2. Targeting delivery and minimizing epidermal diffusion of tranexamic acid by hyaluronic acid-coated liposome nanogels for topical hyperpigmentation treatment.
Liu Y; Han Y; Zhu T; Wu X; Yu W; Zhu J; Shang Y; Lin X; Zhao T
Drug Deliv; 2021 Dec; 28(1):2100-2107. PubMed ID: 34596008
[TBL] [Abstract][Full Text] [Related]
3. Effect of a Tranexamic Acid, Kojic Acid, and Niacinamide Containing Serum on Facial Dyschromia: A Clinical Evaluation.
Desai S; Ayres E; Bak H; Manco M; Lynch S; Raab S; Du A; Green D; Skobowiat C; Wangari-Talbot J; Zheng Q
J Drugs Dermatol; 2019 May; 18(5):454-459. PubMed ID: 31141852
[TBL] [Abstract][Full Text] [Related]
4. In vitro human skin concentrations following topical application of 2% tranexamic acid in co-enhancer cream and branded cream formulations.
Ng SP; Marcant M; Davis AF
J Cosmet Dermatol; 2020 Oct; 19(10):2656-2662. PubMed ID: 31961048
[TBL] [Abstract][Full Text] [Related]
5. Oral tranexamic acid in the treatment of hyperpigmentation disorder beyond melasma: A review.
Mahjoub TT; Milibary HH
J Cosmet Dermatol; 2023 Apr; 22(4):1157-1162. PubMed ID: 36575866
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy and safety of intralesional injection of tranexamic acid and the topical application of Kligman combination drug in the treatment of macular amyloidosis.
Ghassemi M; Roohaninasab M; Kamani SA; Sadeghzadeh-Bazargan A; Goodarzi A
Dermatol Ther; 2022 Jan; 35(1):e15213. PubMed ID: 34797597
[TBL] [Abstract][Full Text] [Related]
7. Histological changes in facial melasma after treatment with triple combination cream with or without oral tranexamic acid and/or microneedling: A randomised clinical trial.
Cassiano DP; Espósito ACC; Hassun KM; Lima MMDA; Lima EVA; Miot LDB; Miot HA; Bagatin E
Indian J Dermatol Venereol Leprol; 2022; 88(6):761-770. PubMed ID: 35389028
[TBL] [Abstract][Full Text] [Related]
8. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial.
Kanechorn Na Ayuthaya P; Niumphradit N; Manosroi A; Nakakes A
J Cosmet Laser Ther; 2012 Jun; 14(3):150-4. PubMed ID: 22506692
[TBL] [Abstract][Full Text] [Related]
9. Biocompatible polymer microneedle for topical/dermal delivery of tranexamic acid.
A Machekposhti S; Soltani M; Najafizadeh P; Ebrahimi SA; Chen P
J Control Release; 2017 Sep; 261():87-92. PubMed ID: 28645793
[TBL] [Abstract][Full Text] [Related]
10. Tranexamic acid in treatment of melasma: A comprehensive review of clinical studies.
Taraz M; Niknam S; Ehsani AH
Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28133910
[TBL] [Abstract][Full Text] [Related]
11. Management of hyperpigmentation: Current treatments and emerging therapies.
Nautiyal A; Wairkar S
Pigment Cell Melanoma Res; 2021 Nov; 34(6):1000-1014. PubMed ID: 33998768
[TBL] [Abstract][Full Text] [Related]
12. Microneedling with cutaneous delivery of topical agents for the treatment of melasma: A systematic review.
Brasil Dos Santos J; Nagem Lopes LP; de Lima GG; Teixeira da Silva R; da Silva E Souza Lorca B; Miranda Pinheiro G; Faria de Freitas ZM
J Cosmet Dermatol; 2022 Nov; 21(11):5680-5695. PubMed ID: 35933690
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the Safety and Efficacy of a Topical Formulation Containing Epidermal Growth Factor, Tranexamic Acid, Vitamin C, Arbutin, Niacinamide and Other Ingredients as Hydroquinone 4% Alternatives to Improve Hyperpigmentation: A Prospective, Randomized, Controlled Split Face Study.
Kalasho BD; Minokadeh A; Zhang-Nunes S; Zoumalan RA; Shemirani NL; Waldman AR; Pletzer V; Zoumalan CI
J Cosmet Sci; 2020; 71(5):263-290. PubMed ID: 33022197
[TBL] [Abstract][Full Text] [Related]
14. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation.
Na JI; Choi SY; Yang SH; Choi HR; Kang HY; Park KC
J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):1035-9. PubMed ID: 22329442
[TBL] [Abstract][Full Text] [Related]
15. A Randomized Trial of Oral Tranexamic Acid With Fluocinolone-Based Triple Cream Versus Fluocinolone Based Triple Cream Alone for the Treatment of Melasma.
Perveen S; Rubin A; Berger L; Xiong W; Waqas N; Sharif S; Rao B
J Drugs Dermatol; 2022 Mar; 21(3):321-322. PubMed ID: 35254752
[TBL] [Abstract][Full Text] [Related]
16. Novel dissolving microneedles preparation for synergistic melasma therapy: Combined effects of tranexamic acid and licorice extract.
Xing M; Wang X; Zhao L; Zhou Z; Liu H; Wang B; Cheng A; Zhang S; Gao Y
Int J Pharm; 2021 May; 600():120406. PubMed ID: 33711468
[TBL] [Abstract][Full Text] [Related]
17. A Review of Oral Therapies for the Treatment of Skin Hyperpigmentation.
Shimshak SJE; Tolaymat LM; Haga CB; Dawson NL; Gillis MS; Yin M; Kirsch B; Cooper M; Sluzevich JC
J Cutan Med Surg; 2022; 26(2):169-175. PubMed ID: 34541912
[TBL] [Abstract][Full Text] [Related]
18. Design and development of tranexamic acid loaded film-forming gel to alleviate melasma.
Chevala NT; Dsouza JA; Saini H; Kumar L
J Cosmet Dermatol; 2022 Dec; 21(12):6863-6874. PubMed ID: 36181344
[TBL] [Abstract][Full Text] [Related]
19. Tranexamic acid in melasma: A focused review on drug administration routes.
Konisky H; Balazic E; Jaller JA; Khanna U; Kobets K
J Cosmet Dermatol; 2023 Apr; 22(4):1197-1206. PubMed ID: 36606378
[TBL] [Abstract][Full Text] [Related]
20. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
